India, China and Other Emerging Markets

Key Prospects for Interventional Cardiac

Device Manufactures

Research PREVIEW for the

The Global Emerging Interventional Cardiac

Devices Market

Sample of Key Highlights

• The total revenue generated by sales of emerging interventional cardiac devices

globally in 2013 was estimated to represent a X% increase over the 2012 revenue.

• Revenue in the US market is projected to grow at a compound annual growth rate

(CAGR) of X%, whereas revenue is projected to grow in the European market at X%

and in Rest of World (ROW) at X%, indicating the highest growth.

• The emerging interventional cardiac devices market is currently in its growth phase;

this is attributed to increased levels of awareness of various technologies including

renal denervation (RDN), fractional flow reserve (FFR), and left atrial appendage (LAA)

and the availability of various products in the market.

• With the availability of innovative technologies and strong clinical data evidence, the

interventional cardiac devices market is expected to gain momentum in the

marketplace.

• The US and European markets are the highest-growing regions in the interventional

cardiology space; however, the growth in these regions is likely to be offset by low

procedural volumes and declining average selling prices (ASPs).

Source: Frost & Sullivan analysis.

Sample of Key Highlights

• With the increase in life expectancy and an aging baby-boomer population as well as

the surge in cardiac morbidities, the need for the emerging interventional cardiology

market is bound to increase dramatically by 2020.

• Of Brazil, Russia, India, China (BRIC), South Africa, and South Korea, India and China

contribute the highest growth in terms of CAGR and are a step ahead of regions such

as South Korea and Russia.

• Nonetheless, the BRIC interventional cardiology device market will increase robustly

over the forecast period. Outside of the BRIC nations, other highly targeted countries

include Australia, Turkey, Indonesia, Malaysia, and Mexico.

Source: Frost & Sullivan analysis.

Scope and Segmentation R

es

tra

ints

Restr

ain

ts

Scope

Geographic coverage Global: United States, Europe, and ROW

Study period 2010–2018

Base year 2013

Forecast period 2014–2018

Monetary unit US dollars

Scope and Segmentation

Source: Frost & Sullivan analysis.

• This research service analyses key data and information and provides an in-depth analysis of the

global emerging interventional cardiac devices market.

• The study period covered by this service for the emerging interventional cardiac devices market is from

2010 to 2020, with a CAGR period from 2013 to 2020; the base year is 2013, and the forecast period is

from 2014 to 2020.

• The key geographic areas covered in this study include the United States, Europe, and ROW.

• The 5 key segments covered in this study include transcatheter aortic valve replacement (TAVR), renal

denervation (RDN), bronchial thermoplasty (BT), bioresorbable stents, and FFR. This study does not

include other emerging interventional device market segments.

• This study looks at a series of emerging early-stage interventional technologies; as such, it is approved

as is, and there does not need to be an aggregate total market forecast.

• Revenue for emerging interventional cardiac devices manufacturing companies was obtained from

companies’ annual reports and financial statements.

Executive Summary — CEO’s Perspective

Source: Frost & Sullivan analysis.

2 Significant growth of RDN is expected from various other regions, including Canada, Australia, and Latin America.

3 Favourable demographics will continue to drive the adoption of interventional cardiac devices in growing economies.

4 Technology advances will be witnessed especially in areas of bioresorbable stents and LAA.

5 A significant rise in revenue of coronary stents will be witnessed due to the growing adoption of premium-priced drug-eluting stents.

1 Drug-eluting stents may present regulatory and reimbursement challenges across different

regions.

Executive Summary — 3 Big Predictions

Source: Frost & Sullivan analysis.

2 The price of the devices is increasingly becoming a major factor in competitiveness.

3 An increase in minimally invasive procedures is expected to drive the growth of the market in the next few years.

1 With the increasing use of interventional cardiac procedures, the APAC region is under tremendous pressure to increase the number of trained and skilled medical personnel.

Details of the Full Analysis

The Full Analysis Features the Following Content

Section Slide Numbers

Executive Summary 9

Market Overview 18

Competitive Playbook 26

Drivers, Restraints, and Trends 32

Forecasts and Trends 41

Market Share and Competitive Analysis 53

Transcatheter Heart Valves Segment Breakdown 55

Renal Denervation Segment Breakdown 68

Bronchial Thermoplasty Segment Breakdown 80

Bioresorbable Stents Segment Breakdown 89

Fractional Flow Reserve Segment Breakdown 99

Country Snapshot—United States 108

Country Snapshot—Europe 111

The Full Analysis Features the Following Content

Section Slide Numbers

The Last Word 117

Appendix 121

Decision Support Database 125

Key Questions the Full Analysis Answers

Source: Frost & Sullivan analysis.

Is the interventional cardiac devices market growing, how long will it continue to grow, and at what rate?

What are the key drivers and trends that lead to growth opportunities?

Which are the most promising segments for manufacturing companies to venture into? Who are the key market participants in each segment?

What market predictions for the forecast period will likely affect manufacturers in the interventional cardiac devices market?

Are the products and services offered today meeting customer needs, or is additional development needed?

What are the trends in use and technology, and is there a shift towards any particular product segment?

List of Exhibits

Source: Frost & Sullivan research.

Exhibit Slide Number

Total Emerging Interventional Cardiac Devices Market: Global, 2013 15

Total Emerging Interventional Cardiac Devices Market: Market Segmentation, Global, 2013 19

Total Emerging Interventional Cardiac Devices Market: Key Market Drivers and Restraints, Global, 2014–2020

33

Total Emerging Interventional Cardiac Devices Market: Market Engineering Measurements, Global, 2013

42

Total Emerging Interventional Cardiac Devices Market: Procurement Process, Global, 2013 51

Total Interventional Cardiac Devices Market: Competitive Structure, Global, 2013 54

Transcatheter Heart Valves Segment: Market Engineering Measurements, Global, 2013 58

Transcatheter Heart Valves Segment: Revenue Forecast, Global, 2010–2020 59

Transcatheter Heart Valves Segment: Market Participants, Global, 2013 64

Transcatheter Heart Valves Segemnt: Comparison of Key TAVR Products, Global, 2013 65

List of Exhibits

Source: Frost & Sullivan research.

Exhibit Slide Number

Transcatheter Heart Valves Segment: Percent of Sales, Global, 2013 66

Transcatheter Heart Valves Segment: Competitive Structure, Global, 2013 67

Renal Denervation Segment: Market Engineering Measurements, Global, 2013 71

Renal Denervation Segment: Revenue Forecast, Global, 2010–2020 72

Renal Denervation Segment: Market Participants, Global, 2013 76

Renal Denervation Segment: Worldwide Market Opportunity, Global, 2013 77

Renal Devervation Segment: Percent of Sales, Global, 2013 78

Renal Denervation Segment: Competitive Structure, Global, 2013 79

Bronchial Thermoplasty Segment: Market Engineering Measurements, Global, 2013 82

Bronchial Thermoplasty Segment: Revenue Forecast, Global, 2010–2020 83

List of Exhibits

Source: Frost & Sullivan research.

Exhibit Slide Number

Bronchial Thermoplasty Segment: Percent of Sales, Global, 2013 87

Bronchial Thermoplasty Segment: Competitive Structure, Global, 2013 88

Bioresorbable Stents Segment: Market Engineering Measurement, Global, 2013 91

Bioresorbable Stents Segment: Revenue Forecast, Global, 2010–2020 92

Bioresorbable Stents Segment: Product Development Status, Global, 2013 96

Bioresorbable Stents Segment: Percent of Sales, Global, 2013 97

Bioresorbable Stents Segment: Competitive Structure, Global, 2013 98

Fractional Flow Reserve Segment: Market Engineering Measurement, Global, 2013 101

Fractional Flow Reserve Segment: Revenue Forecast, Global, 2010–2020 102

Fractional Flow Reserve Segment: Major Market Participants, Global, 2013 105

List of Exhibits

Source: Frost & Sullivan research.

Exhibit Slide Number

Fractional Flow Reserve Segment, Percent of Sales, Global, 2013 106

Fractional Flow Reserve Segment: Competitive Structure, Global, 2013 107

Decision Support Database: Prevalence of Cardiovascular Diseases , Global, 2002–2012

126

Decision Support Database: Population with Hypertension, Global, 2002–2012 127

Decision Support Database: Population Aged Above 65 Years, Global, 2007–2017 128

Associated Multimedia

Analyst Briefings Healthcare & Life Sciences http://bit.ly/1fnYtaN

SlideShare Presentations Healthcare & Life Sciences http://slidesha.re/1hmrb0l

Market Insight Articles Complimentary Healthcare & Life Sciences Analyst Insights http://bit.ly/1hcgeig

GIL Community Frost & Sullivan Community of Growth, Innovation and Leadership http://gil-events.gilcommunity.com/

Analyst Blogs Healthcare & Life Sciences http://bit.ly/1ckACZP

Interested in Full Access? Connect With Us

Jennifer Carson North America Corporate Communications

(210) 247-2450

jennifer.carson@frost.com

Research Authors

Swathi Allada Research Analyst

Advanced Medical Technologies

Venkat Rajan Principal Analyst

Advanced Medical Technologies

Siddharth Saha Global Research

Director Advanced Medical

Technologies

Facebook https://www.facebook.com/FrostandSullivan

LinkedIn Group https://www.linkedin.com/company/frost-&-sullivan

SlideShare http://www.slideshare.net/FrostandSullivan

Twitter https://twitter.com/Frost_Sullivan

Global Perspective 40+ Offices Monitoring for Opportunities and Challenges

Industry Convergence Comprehensive Industry Coverage Sparks Innovation Opportunities

Automotive &

Transportation

Aerospace & Defense Measurement &

Instrumentation

Information &

Communication Technologies

Healthcare Environment & Building

Technologies

Energy & Power

Systems

Chemicals, Materials

& Food

Electronics &

Security

Industrial Automation

& Process Control

Automotive

Transportation & Logistics

Consumer

Technologies

Minerals & Mining